Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009-2011

Journal of Microbiology

Volumn 50, Issue 6, 2012, Pages 1067-1070

  Park, Sehee ^a   Kim, Jin Il ^a   Lee, Ilseob ^a   Lee, Sangmoo ^a   Hwang, Min Woong ^a   Bae, Joon Yong ^a   Heo, Jun ^a   Lim, Eun Joo ^b   Seok, Won Seok ^b   Cheong, Hee Jin ^c   Song, Joon Young ^c   Kim, Woo Joo ^c   Park, Man Seong ^a  

^a Hallym University   (South Korea)

^b Gangwon Research Institute of Health and Environment   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

influenza; neuraminidase; oseltamivir

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VIRUS HEMAGGLUTININ; OSELTAMIVIR; SIALIDASE;

ANTIVIRAL RESISTANCE; ARTICLE; DRUG EFFECT; GENETICS; HUMAN; INFLUENZA; INFLUENZA VIRUS A H3N2; MICROBIAL SENSITIVITY TEST; MUTATION; SOUTH KOREA; VIRUS CULTURE;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MICROBIAL SENSITIVITY TESTS; MUTATION; NEURAMINIDASE; OSELTAMIVIR; REPUBLIC OF KOREA; VIRAL PLAQUE ASSAY;

ORTHOMYXOVIRIDAE;

EID: 84871800151     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-012-2541-3     Document Type: Article

References (20)

1. Abed, Y., Bourgault, A. M., Fenton, R. J., Morley, P. J., Gower, D., Owens, I. J., Tisdale, M., and Boivin, G. 2002. Characterization of 2 influenza a(h3n2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene. J. Infect. Dis. 186, 1074-1080.
2. Aoki, F. Y., Boivin, G., and Roberts, N. 2007. Influenza virus susceptibility and resistance to oseltamivir. Antivir. Ther. 12, 603-616.
3. Baek, Y. H., Park, J. H., Song, Y. J., Song, M. S., Pascua, P. N., Hahn, Y. S., Han, H. S., Lee, O. J., Kim, K. S., Kang, C., andet al. 2009. Molecular characterization and phylogenetic analysis of h3n2 human influenza a viruses in cheongju, south Korea. J. Microbiol. 47, 91-100.
4. CDC. 2008. Influenza activity - united states and worldwide, 2007-08 season. MMWR Morb. Mortal Wkly Rep. 57, 692-697.
5. CDC. 2009. Update: Influenza activity - united states, September 28, 2008-January 31, 2009. MMWR Morb. Mortal Wkly Rep. 58, 115-119.
6. CDC. 2010. Update: Influenza activity - united states, 2009-10 season. MMWR Morb. Mortal Wkly Rep. 59, 901-908.
7. CDC. 2011. Update: Influenza activity - united states, 2010-11 season, and composition of the 2011-12 influenza vaccine. MMWR Morb. Mortal Wkly Rep. 60, 705-712.
8. Fodor, E., Devenish, L., Engelhardt, O. G., Palese, P., Brownlee, G. G., and Garcia-Sastre, A. 1999. Rescue of influenza a virus from recombinant DNA. J. Virol. 73, 9679-9682.
9. Gubareva, L. V. 2004. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res. 103, 199-203.
10. Hauge, S. H., Dudman, S., Borgen, K., Lackenby, A., and Hungnes, O. 2009. Oseltamivir-resistant influenza viruses a (h1n1), norway, 2007-08. Emerg. Infect. Dis. 15, 155-162.
11. Kim, J. I., Park, S., Lee, I., Lee, S., Shin, S., Won, Y., Hwang, M. W., Bae, J. Y., Heo, J., Hyun, H. E., andet al. 2012. Gfp-expressing influenza a virus for evaluation of the efficacy of antiviral agents. J. Microbiol. 50, 359-362.
12. Kiso, M., Mitamura, K., Sakai-Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F. G., Sugaya, N., and Kawaoka, Y. 2004. Resistant influenza a viruses in children treated with oseltamivir: Descriptive study. Lancet. 364, 759-765.
13. Kwon, D., Shin, K., Kim, S., Ha, Y., Choi, J. H., Yang, J. S., Lee, J. Y., Chae, C., Oh, H. B., and Kang, C. 2010. Replication and pathogenesis of the pandemic (h1n1) 2009 influenza virus in mammalian models. J. Microbiol. 48, 657-662.
14. McKimm-Breschkin, J., Trivedi, T., Hampson, A., Hay, A., Klimov, A., Tashiro, M., Hayden, F., and Zambon, M. 2003. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob. Agents Chemother. 47, 2264-2272.
15. Meijer, A., Lackenby, A., Hungnes, O., Lina, B., van-der-Werf, S., Schweiger, B., Opp, M., Paget, J., van-de-Kassteele, J., Hay, A., andet al. 2009. Oseltamivir-resistant influenza virus a (h1n1), europe, 2007-08 season. Emerg. Infect. Dis. 15, 552-560.
16. NISN. 2012. Neuraminidase inhibitor susuceptibility network. Virological assay - laboratory tests of neuraminidase inhibition. (http://www. nisn. org/v_laboratory_tests. html, accessed on october 3, 2012).
17. Okomo-Adhiambo, M., Sleeman, K., Ballenger, K., Nguyen, H. T., Mishin, V. P., Sheu, T. G., Smagala, J., Li, Y., Klimov, A. I., and Gubareva, L. V. 2010. Neuraminidase inhibitor susceptibility testing in human influenza viruses: A laboratory surveillance perspective. Viruses2, 2269-2289.
18. Sheu, T. G., Deyde, V. M., Okomo-Adhiambo, M., Garten, R. J., Xu, X., Bright, R. A., Butler, E. N., Wallis, T. R., Klimov, A. I., and Gubareva, L. V. 2008. Surveillance for neuraminidase inhibitor resistance among human influenza a and b viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 52, 3284-3292.
19. Tisdale, M. 2000. Monitoring of viral susceptibility: New challenges with the development of influenza NA inhibitors. Rev. Med. Virol. 10, 45-55.
20. WHO. 2012. Influenza update (update number 154): Countries in the temperate zone of the nothern hemisphere (www. who. int/influenza/surveillance_monitoring/updates/2012_03_02_gip_surveillance/en/index. html#northern).